PCVX: the cash flow

MyFinsight

For the year ending 2025-12-31, PCVX had -$213,770K decrease in cash & cash equivalents over the period. -$669,290K in free cash flow.

Cash Flow	2025-12-31
Net loss	-766,628
Depreciation and amortization	16,396
Stock-based compensation expense	138,845
Amortization of operating lease right-of-use assets	8,464
Net accretion of discounts on investments	14,434
Unrealized foreign exchange loss (gain)	34,768
Prepaid expenses and other current assets	16,800
Operating lease right-of-use assets	52,371
Other assets	39,886
Operating lease liabilities	46,371
Accounts payable	19,906
Accrued compensation	2,302
Accrued contract manufacturing expenses	31,059
Accrued expenses	5,967
Net cash used in operating activities	-655,577
Purchases of property and equipment	13,713
Purchases of manufacturing facility build-out and equipment construction-in-progress	43,260
Purchases of investments	1,211,499
Maturities of investments	1,531,136
Sales of investments	174,690
Net cash provided by (used in) investing activities	437,354
Proceeds from issuance of common stock and pre-funded warrants from follow-on offerings, net of issuance costs	0
Proceeds from issuance of common stock under at-the-market offering, net of issuance costs	0
Proceeds from issuance of shares through employee equity incentive plans	13,005
Taxes paid related to the net share settlement of equity awards	10,991
Net cash provided by financing activities	2,014
Effect of exchange rate changes on cash and cash equivalents	2,439
Net decrease in cash, cash equivalents and restricted cash	-213,770
Cash, cash equivalents and restricted cash, beginning of period	389,195
Cash, cash equivalents and restricted cash, end of period	175,425

Unit: Thousand (K) dollars (except for numbers of shares and EPS).